These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7727640)

  • 1. Adjunctive therapy for septic shock: a review of experimental approaches.
    Lynn WA; Cohen J
    Clin Infect Dis; 1995 Jan; 20(1):143-58. PubMed ID: 7727640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging therapies for sepsis and septic shock.
    Oh HM
    Ann Acad Med Singap; 1998 Sep; 27(5):738-43. PubMed ID: 9919353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiendotoxin therapies for septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):44-52. PubMed ID: 8162353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.
    Van Amersfoort ES; Van Berkel TJ; Kuiper J
    Clin Microbiol Rev; 2003 Jul; 16(3):379-414. PubMed ID: 12857774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions.
    Opal SM; Yu RL
    Drugs; 1998 Apr; 55(4):497-508. PubMed ID: 9561340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock.
    Calandra T; Baumgartner JD; Glauser MP
    Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria.
    Lamping N; Dettmer R; Schröder NW; Pfeil D; Hallatschek W; Burger R; Schumann RR
    J Clin Invest; 1998 May; 101(10):2065-71. PubMed ID: 9593762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide binding protein: its role and therapeutical potential in inflammation and sepsis.
    Schumann RR; Lamping N; Kirschning C; Knopf HP; Hoess A; Herrmann F
    Biochem Soc Trans; 1994 Feb; 22(1):80-2. PubMed ID: 7515836
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sepsis syndrome: progress and therapeutic perspectives].
    Schaller MD
    Schweiz Med Wochenschr; 1992 May; 122(20):768-75. PubMed ID: 1604283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunologic therapy for ARDS, septic shock, and multiple-organ failure.
    St John RC; Dorinsky PM
    Chest; 1993 Mar; 103(3):932-43. PubMed ID: 8449096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sepsis and septic shock. II. Treatment.
    Mayer J; Hajek R; Vorlicek J; Tomiska M
    Support Care Cancer; 1995 Mar; 3(2):111-9. PubMed ID: 7773578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern approaches to the therapy of septic shock.
    Putterman C
    Am J Emerg Med; 1990 Mar; 8(2):152-61. PubMed ID: 2405867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of endotoxin response by e5564, a novel Toll-like receptor 4-directed endotoxin antagonist.
    Mullarkey M; Rose JR; Bristol J; Kawata T; Kimura A; Kobayashi S; Przetak M; Chow J; Gusovsky F; Christ WJ; Rossignol DP
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1093-102. PubMed ID: 12604686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel therapies for sepsis: antiendotoxin therapies.
    Manocha S; Feinstein D; Kumar A; Kumar A
    Expert Opin Investig Drugs; 2002 Dec; 11(12):1795-812. PubMed ID: 12457439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abdominal Septic Shock - Endotoxin Adsorption Treatment (ASSET) - endotoxin removal in abdominal and urogenital septic shock with the Alteco® LPS Adsorber: study protocol for a double-blinded, randomized placebo-controlled trial.
    Lipcsey M; Tenhunen J; Sjölin J; Frithiof R; Bendel S; Flaatten H; Kawati R; Kuitunen A; Tønnessen TI; Rubertsson S
    Trials; 2016 Dec; 17(1):587. PubMed ID: 27931259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin as a therapeutic target in septic shock.
    Corriveau CC; Danner RL
    Infect Agents Dis; 1993 Feb; 2(1):35-43. PubMed ID: 8162352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical sepsis trials.
    Abraham E
    Chest; 1994 Mar; 105(3 Suppl):53S-55S. PubMed ID: 8131613
    [No Abstract]   [Full Text] [Related]  

  • 18. New treatments for sepsis.
    Mercier JC
    Crit Care Med; 1993 Sep; 21(9 Suppl):S310-4. PubMed ID: 8365201
    [No Abstract]   [Full Text] [Related]  

  • 19. Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials.
    Chen X; Zhu W; Tan J; Nie H; Liu L; Yan D; Zhou X; Sun X
    Oncotarget; 2017 Apr; 8(16):27510-27519. PubMed ID: 28460438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current prospects for the treatment of clinical sepsis.
    Suffredini AF
    Crit Care Med; 1994 Jul; 22(7):S12-8. PubMed ID: 8026188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.